[226 Pages Report] Europe radiotherapy patient positioning market is set to display a substantial growth at 4.1% CAGR from 2022 to 2032, surpassing US$ 124.9 Million in 2022. In terms of product type, the markers segment holds a substantial share of about 30.0% of Europe’s radiotherapy patient positioning market in 2022.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Europe Radiotherapy Patient Positioning Market Value 2022 | US$ 120.3 Million |
| Market Value 2022 | US$ 124.9 Million |
| Market Value 2032 | US$ 187.1 Million |
| CAGR 2022 to 2032 | 4.1% |
| Market Share of Top 5 Companies | 27.9% |
With the increase in cancer diagnosis at early stages, radiotherapy is one of the first options as a treatment for early detected cancers. Furthermore, the growing demand for minimally invasive procedures is driving the growth in the radiotherapy patient positioning market.
As the number of cancer cases is increasing, the mortality rate associated with various cancer stages has been surging. Hence, to avoid the consequences people suffering from the conditions seek clinical attention soon after the diagnosis.
This has to lead the healthcare sector to improve the quality of infrastructure boosting the market in the given forecast period. According to Future Market Insights, the market is a highly fragmented market predominantly occupied by companies headquartered in the Scandinavia of Europe Regions. With the growing adoption of radiation therapy, the growth in the radiotherapy patient positioning market is predicted to surge in Europe.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Europe radiotherapy patient positioning market expanded at a CAGR of 2.7% over the last five years (2017 to 2021). The market value for radiotherapy patient positioning holds nearly 2.0% of the overall ~US$ 5.9 Billion global radiotherapy market in 2021.
Every cancer patient undergoing radiotherapy has to undergo radiotherapy planning since every cancer is unique to a patient. The odd locations of cancers force patients to stay in an odd position throughout the duration of each radiotherapy session.
This has created the need to develop products to maintain the position of the patient as well as address the patient’s comfort since a comfortable patient is more cooperative during the procedure. With the rising adoption of personalized medicine and its application in radiotherapy has created a demand for patient comfort during the procedure.
Increasing awareness of cancer can lead to the early detection of a number of cancers that could be treated at an early stage. Cancer detected at an early stage could be treated through surgery or radiation therapy.
Further, radiotherapy is an important part of the multidisciplinary treatment technique for a wide variety of cancers. For individual sufferers, most cancer care centres aim treatments for prolonging survival and/or enhancing health-associated lifestyles.
As cancer rates are increasing, healthcare professionals are introducing new methods and ways to bring out better patient outcomes. This has brought advancements in new and improved technologies that help in precise dosage forms.
These technologies include CT scans which aid in giving radiotherapists the ability to take multiple 2D photos, referred to as slices, and turn them into a 3-D view of the tumour and surrounding organs. Intensity-modulated radiation therapy (IMRT) is another important advancement which controls the intensity of the beams.
The dose of radiation may be managed more strictly, with its intensity improved near the gross tumour extent and reduced or nullified completely whilst directed at neighbouring healthful tissues. Stereotactic radiosurgery is a method to remove a tumour via a surgical procedure that results in completely curing cancer or part of it.
On the back of these aforementioned factors, the market is expected to expand at a CAGR of 4.1%, creating an absolute $ opportunity of US$ 4.9 Million by 2032.
As per FMI, radiotherapy patient positioning market manufacturers include technology advancements and collaboration.
Development and advancement in radiation therapy systems provide significant opportunities for radiotherapy patient positioning providers. With the development of new technology, the need for more compatible devices is rising.
Since the radiotherapy patient positioning market is directly related to the radiotherapy market. Advances and growth in the radiotherapy market will directly have a positive impact on the radiotherapy patient positioning market.
Collaboration with hospitals and radiation centres for the supply of products such as thermoplastic masks, sheets, cushions, and other similar devices. This is expected to provide a huge opportunity for manufacturers over the forecast period.
Due to the fragmented nature of the radiotherapy patient positioning market. Partnerships provide significant opportunities for the growth of one’s company within the market. Distribution partnerships are the most favourable for extending product reach globally. However, acquisitions and mergers also could result in a favourable growth in the radiotherapy patient positioning market.
Principal Consultant
The availability of alternative therapies, as well as a dearth of skilled people, are limiting the demand in the radiotherapy patient positioning market.
When it comes to providing radiation treatment to patients, skilled human resources such as radiologists, dosimetrists, nurses, and other hospital staff are crucial. Currently, there is a global scarcity of skilled and certified professionals.
Lancet Oncology also estimates that another 215,000 specialists will be needed by 2035. Hence, the lack of a skilled workforce is a significant restraint on the growth of the radiotherapy patient positioning market.
Alternative cancer treatments, such as immunotherapy and breast lesion localization devices, have been developed successfully. Nowadays, there is a lot of emphasis on creating painless unique positioning, which, unfortunately, limits market expansion.
According to Cancer Research UK, patients in England are also more likely to have surgery and chemotherapy in the early stages of cancer. This alternative treatment option is restraining the market growth.
Growing Prevalence of Cancer Among Geriatric Population to Push the Demand for Radiotherapy Patient Positioning
As per FMI, DACH will dominate the Europe radiotherapy patient positioning market with a total share of about 18.5% in 2022. The rising geriatric population is expected to drive the growth in Europe's radiotherapy patient positioning market since people aged above 60 years are at a high risk of developing cancers.
According to the World Data Atlas, in 2021, people 63 years and above in Germany 21%. Also, the number of the older population has increased from 14.2% in 1972 to 21% in 2021 rising at an average annual rate of 0.91%.
Scandinavia Radiotherapy Patient Positioning Market to Benefit from Increasing Number of Radiotherapy Centers
Scandinavia is set to exhibit a CAGR of nearly 3.0% in the Europe radiotherapy patient positioning market during the forecast period. The growth is attributed to the rising number of radiotherapy centers. Radiotherapy is an important part of the multidisciplinary treatment technique for a wide variety of cancers.
In Norway, research showed that radiotherapy use increased extensively after the implementation of the Norwegian Cancer Plan to multiply radiotherapy ability (2018).
Advancements in Radiology Technologies will Steer the Italy Radiotherapy Patient Positioning Market at a Significant Rate
Italy accounted for over 14.2% market share in the Europe market in 2021 and is expected to increase at a CAGR of 5.4% during the forecast period. Advanced radiotherapy technologies are being developed in Italy, to treat a range of tumors.
Radiation therapy is an important aspect in treating various cancer and increasing the survival rate to 72% with 3D radiation therapy. Furthermore, the advancement in modulated radiation therapy (IMRT) and stereotactic radiosurgery and radiotherapy (SRS and SRT) has brought ineffective management of cancer. These advancements will drive the growth in Italy's radiotherapy patient positioning market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Need for Markers in Radiotherapy Patient Positioning to Find the Tumour will Drive the Sales
Based on product type, the markers segment is leading with a market share of over 30.0% in 2022. Markers help find the location of a tumour, supporting radiation and giving the person to deliver the maximum dosage of radiation to the tumour.
It also helps in minimizing the dose so that healthy tissue is not get damaged. This advanced feature which gives accuracy, efficacy and safety in tumour detection drives the demand in near future.
Radiation/Proton Therapy Centers to Account for Significant Share in Europe Radiotherapy Patient Positioning Market
Radiation/proton therapy centres are expected to lead the radiotherapy patient positioning market with an estimated market share of about 45.1% market share in 2022. Radiation therapy is done majorly in radiation therapy centres due to which there is more walk-in patient within radiation/proton therapy centres.
Key manufacturers are working towards the development of innovative products that are not only suitable and required for radiation patient positioning but also for increasing the comfort level of patients.
Hence, most manufacturers are focused on the development and approval of new products. They are also opting for merger and acquisition strategies to strengthen their market presence.
Similarly, recent developments related to companies manufacturing Radiotherapy patient positioning products have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value and Volume ('000 Units) |
| Key Regions Covered | Europe |
| Key Countries Covered | Denmark, Sweden, Norway, Finland, Germany, Austria, Switzerland, Belgium, Netherlands, Luxembourg, France, Italy, Spain, Portugal, and Poland. |
| Key Market Segments Covered | Product Type, End User, and Country |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
Europe Radiotherapy patient positioning market estimated worth is US$ 124.9 Million in (2022) and is set to expand 1.4X over the next ten years.
Europe radiotherapy patient positioning market is expected to reach US$ 187.1 Million by the end of 2032, with sales revenue expected to register 4.1% CAGR.
Scandinavia, DACH Region and Italy are expected to drive demand for Europe radiotherapy patient positioning market.
Demand for Radiotherapy patient positioning in Europe is expected to register a growth of 4.1%over the next ten years.
Orfit Industries, Eckert & Ziegler BEBIG, CIVCO Radiotherapy, IZI Medical Products, and Best Medical Canada are the key manufacturers of Europe’s radiotherapy patient positioning market.
1. Executive Summary | Europe Radiotherapy Patient Positioning Market 1.1. Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Europe GDP Growth Outlook 4.1.2. Per Capita Healthcare Expenditure Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. Rising Incidence of Cancer 4.2.2. Diagnosis Rate (%) 4.2.3. Adoption of Patient Position Device 4.2.4. Cost Per Device 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 5. Key Success Factors 5.1. Regulatory Scenario 5.2. Cancer Epidemiology 5.3. Key Branding & Promotional Strategies, By Key Manufacturers 5.4. PESTLE Analysis 5.5. Porter’s Analysis 6. Market Demand (in Volume Units) Analysis 2017 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Volume (Units) Analysis, 2017 to 2021 6.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Market - Pricing Analysis 7.1. Regional Pricing Analysis, By Product Type 7.2. Pricing Break-up 7.2.1. Manufacturer-Level Pricing 7.2.2. Distributor Level Pricing 7.3. Europe Average Pricing Analysis Benchmark 8. Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021 8.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume Analysis By Product, 2017 to 2021 9.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast By Product, 2022 to 2032 9.3.1. Thermoplastic Masks & Sheets 9.3.1.1. Head Masks 9.3.1.2. Head & Shoulder Masks 9.3.1.3. Torso & Extremities 9.3.2. Markers 9.3.2.1. Fiducial Markers 9.3.2.2. Vaginal Markers 9.3.2.3. Rectal Marker 9.3.3. Immobilization System 9.3.4. Head Rest 9.3.5. Cushions 9.3.6. Spacers & Wedges 9.3.7. Arm & Wrist Support 9.3.8. Locating & Indexing Bar 9.3.9. Bite Positioners 9.4. Market Attractiveness Analysis By Product 10. Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032 10.3.1.1. Hospitals 10.3.1.2. Cancer Research Institutes 10.3.1.3. Radiation/Proton Therapy Centers 10.4. Market Attractiveness Analysis By End User 11. Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021 11.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032 11.3.1. Scandinavia 11.3.2. DACH Region 11.3.3. Benelux 11.3.4. France 11.3.5. Italy 11.3.6. Spain 11.3.7. Portugal 11.3.8. Poland 11.4. Market Attractiveness Analysis By Region 12. Scandinavia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 12.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 12.3.1. By Country 12.3.1.1. Denmark 12.3.1.2. Sweden 12.3.1.3. Norway 12.3.1.4. Finland 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Market Attractiveness Analysis 12.6. Drivers and Restraints - Impact Analysis 13. DACH Region Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 13.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. Austria 13.3.1.3. Switzerland 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Market Attractiveness Analysis 13.6. Drivers and Restraints - Impact Analysis 14. BENELUX Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 14.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. Belgium 14.3.1.2. Netherlands 14.3.1.3. Luxembourg 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Market Attractiveness Analysis 14.6. Drivers and Restraints - Impact Analysis 15. France Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 15.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 15.3.1. By Product 15.3.2. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Product 15.4.2. By End User 15.5. Market Attractiveness Analysis 15.6. Drivers and Restraints - Impact Analysis 16. Spain Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 16.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 16.3.1. By Product 16.3.2. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Product 16.4.2. By End User 16.5. Market Attractiveness Analysis 16.6. Drivers and Restraints - Impact Analysis 17. Italy Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 17.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 17.3.1. By Product 17.3.2. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Product 17.4.2. By End User 17.5. Market Attractiveness Analysis 17.6. Drivers and Restraints - Impact Analysis 18. Portugal Market Analysis 2017 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 18.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 18.3.1. By Product 18.3.2. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Product 18.4.2. By End User 18.5. Market Attractiveness Analysis 18.6. Drivers and Restraints - Impact Analysis 19. Poland Market Analysis 2017 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2017 to 2021 19.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2032 19.3.1. By Product 19.3.2. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Product 19.4.2. By End User 19.5. Market Attractiveness Analysis 19.6. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies ( Market) 20.2. Market Share Analysis of Top Players 20.3. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1. Orfit Industries 21.3.1.1. Overview 21.3.1.2. Product Portfolio 21.3.1.3. Profitability by Market Segments (Product/Channel/Region) 21.3.1.4. Sales Footprint 21.3.1.5. Strategy Overview 21.3.2. Qfix 21.3.2.1. Overview 21.3.2.2. Product Portfolio 21.3.2.3. Profitability by Market Segments (Product/Channel/Region) 21.3.2.4. Sales Footprint 21.3.3. Strategy Overview 21.3.4. Elekta 21.3.4.1. Overview 21.3.4.2. Product Portfolio 21.3.4.3. Profitability by Market Segments (Product/Channel/Region) 21.3.4.4. Sales Footprint 21.3.5. Strategy Overview 21.3.6. Eckert & Ziegler BEBIG 21.3.6.1. Overview 21.3.6.2. Product Portfolio 21.3.6.3. Profitability by Market Segments (Product/Channel/Region) 21.3.6.4. Sales Footprint 21.3.7. Strategy Overview 21.3.8. CDR Systems 21.3.8.1. Overview 21.3.8.2. Product Portfolio 21.3.8.3. Profitability by Market Segments (Product/Channel/Region) 21.3.8.4. Sales Footprint 21.3.9. Strategy Overview 21.3.10. Roper Technologies-CIVCO 21.3.10.1. Overview 21.3.10.2. Product Portfolio 21.3.10.3. Profitability by Market Segments (Product/Channel/Region) 21.3.10.4. Sales Footprint 21.3.11. Strategy Overview 21.3.12. Best Medical Canada 21.3.12.1. Overview 21.3.12.2. Product Portfolio 21.3.12.3. Profitability by Market Segments (Product/Channel/Region) 21.3.12.4. Sales Footprint 21.3.13. Strategy Overview 21.3.14. Blessing Cathay Corporation 21.3.14.1. Overview 21.3.14.2. Product Portfolio 21.3.14.3. Profitability by Market Segments (Product/Channel/Region) 21.3.14.4. Sales Footprint 21.3.15. Strategy Overview 21.3.16. Candor ApS 21.3.16.1. Overview 21.3.16.2. Product Portfolio 21.3.16.3. Profitability by Market Segments (Product/Channel/Region) 21.3.16.4. Sales Footprint 21.3.17. Strategy Overview 21.3.18. IZI Medical Products 21.3.18.1. Overview 21.3.18.2. Product Portfolio 21.3.18.3. Profitability by Market Segments (Product/Channel/Region) 21.3.18.4. Sales Footprint 21.3.19. Strategy Overview 21.3.20. Klarity Medical Products 21.3.20.1. Overview 21.3.20.2. Product Portfolio 21.3.20.3. Profitability by Market Segments (Product/Channel/Region) 21.3.20.4. Sales Footprint 21.3.21. Strategy Overview 21.3.22. MacroMedics BV 21.3.22.1. Overview 21.3.22.2. Product Portfolio 21.3.22.3. Profitability by Market Segments (Product/Channel/Region) 21.3.22.4. Sales Footprint 21.3.23. Strategy Overview 21.3.24. OSL Oncology Systems Limited. 21.3.24.1. Overview 21.3.24.2. Product Portfolio 21.3.24.3. Profitability by Market Segments (Product/Channel/Region) 21.3.24.4. Sales Footprint 21.3.25. Strategy Overview 21.3.26. T-Tape Company B.V. 21.3.26.1. Overview 21.3.26.2. Product Portfolio 21.3.26.3. Profitability by Market Segments (Product/Channel/Region) 21.3.26.4. Sales Footprint 21.3.27. Strategy Overview 22. Assumptions and Acronyms Used 23. Research Methodology
Healthcare
February 2022
REP-GB-575
May 2024
250 pages
Explore Healthcare Insights
View Reports
Europe Radiotherapy Patient Positioning Market
